NF
BMY icon

NTB Financial’s Bristol-Myers Squibb BMY Stock Holding History

NTB Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$3.34M Sell
43,396
-155
-0.4% -$11.8K 2.71% 3
2022
Q1 		$3.18M Sell
43,551
-48
-0.1% -$3.22K 2.27% 8
2021
Q4 		$2.72M Buy
+43,599
New +$2.56M 1.9% 12

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NTB Financial's BMY Position: Q2 2022 in Review

NTB Financial reduced its Bristol-Myers Squibb (BMY) stake by 0.36% in Q2 2022, selling an estimated $11.8K and leaving 43,396 shares worth $3.34M. The position accounts for 2.71% of the portfolio, ranked #3.

NTB Financial first reported a position in BMY in Q4 2021 and has held it in 3 quarters since. 2,540 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • NTB Financial held 43,396 shares of Bristol-Myers Squibb worth $3.34M as of Q2 2022.
  • NTB Financial sold 155 Bristol-Myers Squibb shares in Q2 2022, an estimated $11.8K.
  • Bristol-Myers Squibb made up 2.71% of NTB Financial's portfolio in Q2 2022, its #3 holding.
  • NTB Financial first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 3 quarters since.
  • 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.